Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-09-25 Sale |
2023-09-25 4:29 pm |
Decibel Therapeutics Inc. | DBTX | FINGER ALISON CECILY Director |
5,000 | $0 | $0 | 0 (Direct) |
View |
| 2021-01-05 Sale |
2021-01-08 5:57 pm |
bluebird bio Inc. | BLUE | FINGER ALISON CECILY Chief Commercial Officer |
1,854 | $45.05 | $83,525 | 25,103 (Direct) |
View |
| 2020-12-02 Sale |
2020-12-04 4:48 pm |
bluebird bio Inc. | BLUE | FINGER ALISON CECILY Chief Commercial Officer |
36 | $46.2 | $1,663 | 26,957 (Direct) |
View |
| 2020-11-02 Sale |
2020-11-04 4:05 pm |
bluebird bio Inc. | BLUE | FINGER ALISON CECILY Chief Commercial Officer |
35 | $52.99 | $1,855 | 26,993 (Direct) |
View |
| 2020-10-02 Sale |
2020-10-06 4:05 pm |
bluebird bio Inc. | BLUE | FINGER ALISON CECILY Chief Commercial Officer |
36 | $52.77 | $1,900 | 27,028 (Direct) |
View |
| 2020-09-03 Sale |
2020-09-08 4:08 pm |
bluebird bio Inc. | BLUE | FINGER ALISON CECILY Chief Commercial Officer |
35 | $58.6 | $2,051 | 27,063 (Direct) |
View |
| 2020-08-03 Sale |
2020-08-05 4:05 pm |
bluebird bio Inc. | BLUE | FINGER ALISON CECILY Chief Commercial Officer |
35 | $60.49 | $2,117 | 27,098 (Direct) |
View |
| 2020-07-02 Sale |
2020-07-07 5:16 pm |
bluebird bio Inc. | BLUE | FINGER ALISON CECILY Chief Commercial Officer |
36 | $61.57 | $2,217 | 27,133 (Direct) |
View |
| 2020-06-02 Sale |
2020-06-04 5:44 pm |
bluebird bio Inc. | BLUE | FINGER ALISON CECILY Chief Commercial Officer |
35 | $64.04 | $2,241 | 27,169 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-19 Option Award |
2025-02-21 9:05 pm |
N/A 2035-02-19 |
ADMA BIOLOGICS INC. | ADMA | FINGER ALISON CECILY Director |
27,168 | $0 | 51,208 (Direct) |
View |
| 2024-02-26 Option Award |
2024-02-28 9:00 pm |
N/A 2034-02-26 |
ADMA BIOLOGICS INC. | ADMA | FINGER ALISON CECILY Director |
61,581 | $0 | 61,581 (Direct) |
View |
Ownership |
2023-10-02 4:46 pm |
N/A 2033-09-28 |
ADMA BIOLOGICS INC. | ADMA | FINGER ALISON CECILY Director |
0 | $0 | 98,870 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-14 4:40 pm |
N/A 2033-06-12 |
Decibel Therapeutics Inc. | DBTX | FINGER ALISON CECILY Director |
5,000 | $0 | 10,000 (Direct) |
View |
| 2022-06-17 Option Award |
2022-06-21 6:55 pm |
N/A 2032-06-16 |
Decibel Therapeutics Inc. | DBTX | FINGER ALISON CECILY Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2021-12-03 Option Award |
2021-12-06 4:17 pm |
N/A 2031-12-02 |
Decibel Therapeutics Inc. | DBTX | FINGER ALISON CECILY Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2020-05-01 Option Award |
2020-05-05 4:06 pm |
N/A N/A |
bluebird bio Inc. | BLUE | FINGER ALISON CECILY Chief Commercial Officer |
1,361 | $0 | 27,204 (Direct) |
View |